Clinical Trials Logo
  1. Home
  2. PET/CT
  3. NCT03423407

Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

PET/CT Clinical Trial

Official title:
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

Clinical Trial Summary

The purpose of this research proposal is to establish a mechanism to develop tools that will allow the investigators to measure the impact of magnetic resonance (MR) acquisition correction sequences for attenuation correction on positron emission tomography (PET) quantitation accuracy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03423407
Study type Observational
Source Washington University School of Medicine
Contact
Status Terminated
Phase
Start date December 14, 2017
Completion date March 2, 2020
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05030597 - Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma N/A
Recruiting NCT05496920 - Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System N/A
Recruiting NCT04577586 - Negative Oral Contrast Agents Utilization in PET/CT Studies
Recruiting NCT04586465 - Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC Phase 2
Recruiting NCT04553601 - Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer N/A
Recruiting NCT05707078 - PET/CT Follow up for Head and Neck Squamous Cell Carcinoma N/A
Recruiting NCT06320223 - PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
Recruiting NCT05255926 - CXCR4-targeted PET/CT Imaging in Hematological Malignancies N/A
Recruiting NCT05955677 - Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis Early Phase 1
Recruiting NCT04588064 - 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma N/A
Active, not recruiting NCT04519255 - Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT
Recruiting NCT05835570 - Integrin αvβ6-targeted PET in Malignant Tumors
Active, not recruiting NCT05819905 - Radiomics for prEdiction of lunG cAncer biologY
Recruiting NCT05034146 - 68Ga-FAPI PET/CT in Malignant Tumors N/A
Recruiting NCT05156515 - PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor N/A
Completed NCT05134064 - 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer
Recruiting NCT03756077 - A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer
Recruiting NCT06462508 - Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis Early Phase 1
Not yet recruiting NCT06353061 - Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer Phase 2
Recruiting NCT06462495 - Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis Early Phase 1